• SMC open account icon Open an A/C
    • Open an A/C
    • CHOOSE YOUR OPTION(S)
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c
  • SENSEX Feb 25 2020 12:00
    40,281.20 -82.03 (-0.20%)
  • NIFTY Feb 25 2020 12:00
    11,797.90 -31.50 (-0.27%)
  • SENSEX Feb 25 2020 12:00
    40,281.20 -82.03 (-0.20%)
  • NIFTY Feb 25 2020 12:00
    11,797.90 -31.50 (-0.27%)
  • Nasdaq Feb 25 2020 04:30
    9,221.28 -355.31 (-3.71%)
  • DJIA Feb 25 2020 04:30
    27,960.80 -1,031.61 (-3.56%)
  • S&P 500 Feb 25 2020 04:30
    3,225.89 -111.86 (-3.35%)
  • Hang Seng Feb 25 2020 02:10
    26,893.23 +72.35 ( +0.27%)
  • Crude Oil Feb 25 2020 11:28
    3,647.00 -15.00 (-0.41%)
  • Gold Feb 25 2020 11:28
    42,766.00 -814.00 (-1.87%)
  • Silver Feb 25 2020 11:28
    47,563.00 -1,842.00 (-3.73%)
  • Copper Feb 25 2020 11:26
    423.10 +0.60 ( +0.14%)
  • Pound / Rupee Dec 23 2016 22:30
    92.95 +0.55 ( +0.60%)
  • Dollar / Rupee Dec 23 2016 22:30
    71.76 +0.08 ( +0.11%)
  • Euro / Rupee Dec 23 2016 22:30
    77.82 +0.44 ( +0.56%)
  • Yen / Rupee Dec 23 2016 22:30
    0.64 0.00 ( +0.29%)

Narmada Gelatines Ltd

BSE Code : 526739 | NSE Symbol : SHAWGELTIN | ISIN:INE869A01010| SECTOR: - |

NSE BSE
 
-/-

0.00

-23.40 -100.00 Volume 280564

04-Jan-2002 09:57:46

Prev. Close

23.40

Open Price

-/-

Bid Price (QTY)

0.00(0)

Offer Price (QTY)

0.00(0)

 

Today’s High/Low -/- - -/-

52 wk High/Low 0.00 - 0.00

Key Stats

MARKET CAP (RS CR) 91.5
P/E 6.52
BOOK VALUE (RS) 217.4687082
DIV (%) 100
MARKET LOT 1
EPS (TTM) 23.19
PRICE/BOOK 0.695502361015082
DIV YIELD.(%) 6.61
FACE VALUE (RS) 10
DELIVERABLES (%)
4

News & Announcements

13-Feb-2020

Narmada Gelatines standalone net profit declines 45.12% in the December 2019 quarter

12-Feb-2020

Narmada Gelatines Ltd - Unaudited Financial Results For The Quarter/Nine Months Ended 31.12.2019.

07-Feb-2020

Narmada Gelatines to announce Quarterly Result

06-Feb-2020

Narmada Gelatines Ltd - Board Meeting Intimation for Board Meeting Is Scheduled On 12Th Feb, 2020

07-Feb-2020

Narmada Gelatines to announce Quarterly Result

07-Nov-2019

Narmada Gelatines to discuss results

28-Aug-2019

Narmada Gelatines to convene AGM

27-Jul-2019

Narmada Gelatines schedules board meeting

Corporate Actions

Bonus
Splits
Dividends
Rights
Capital Structure
Book Closure
Board Meeting
AGM
EGM
 

Financials

Income Statement

Standalone
Consolidated
 

Peers Comparsion

Select Company Name BSE Code NSE Symbol
A-1 Acid Ltd 542012
Aarti Industries Ltd 524208 AARTIIND
Absolute Aromatics Ltd 40209
Aditya Info-Soft Ltd 530693
Advanced Enzyme Technologies Ltd 540025 ADVENZYMES
Akzo Nobel Chemicals (India) Ltd 500082 CENTAKCHEM
Alang Industrial Gases Ltd 531517
Alkali Metals Ltd 533029 ALKALI
Alkyl Amines Chemicals Ltd 506767 ALKYLAMINE
Allied Resins & Chemicals Ltd(merged) 524538 ALLIEDRES
Alufluoride Ltd 524634
Ambani Organics Ltd 535097 AMBANIORG
Amex Carbonates & Chemicals Ltd 531321
Amines & Plasticizers Ltd 506248
Aminex Chemicals Ltd (Wound-up) 524386
Amit Alcohol & Carbon Dioxide Ltd (Merged) 506904
Anan Drug & Chem Ltd 531999
Andhra Petrochemicals Ltd 500012 ANDHRAPET
Anjana Explosives Ltd 40329
Archit Organosys Ltd 524640
Arvin Liquid Gases Ltd 523404
Ashok Alco-Chem Ltd 524594 ASHOKALCO
Asian Petroproducts & Exports Ltd 524434
Asiatic Oxygen Ltd 40030
Avikem Resins Ltd 523784
Avon Lifesciences Ltd 531541
B L Industries (India) Ltd 530637
Balaji Amines Ltd 530999 BALAMINES
Barium Chemcials Ltd 506275
Baroda Carbons Ltd 523527
BASF India Ltd 500042 BASF
Benzo Petro International Ltd 524737
Benzo Petrochemicals Ltd (Wound Up) 524196
Bhagawati Gas Ltd 500051 BAGWATIGAS
Bhagawati Oxygen Ltd 509449
Bhuruka Gases Ltd 509728
Bhuvan Tripura Industries Ltd 524725
Binaca Synthetic Resins Ltd 514344
Bombay Oxygen Investments Ltd 509470
Borax Morarji Ltd(Merged) 506315
Burmah Petro Products Ltd 40310
C J Gelatine Products Ltd 507515
Cabot India Ltd 506700 CABOTINDIA
Camlin Fine Sciences Ltd 532834 CAMLINFINE
Canvay Chemicals Ltd 531535
Caprolactam Chemicals Ltd 507486
Carbon & Chemicals India Ltd (Merged) 505813
Castrol India Ltd 500870 CASTROLIND
Cellulose Products of India Ltd 506345
Chembond Chemicals Ltd 530871 CHEMBOND
Chemcrux Enterprises Ltd 540395
Chemfab Alkalis Ltd 541269 CHEMFAB
Chemiesynth (Vapi) Ltd 539230
Chemplast Sanmar Ltd 506355 CHEMPLAST
Chimique Laboratories (India) Ltd 40300
Ciba India Ltd(merged) 532184 CIBASPEC
Cilson Organics Ltd 532147
Citric India Ltd 506370
Citurgia Biochemicals Ltd 506373 CITURGIBIO
Clariant (India) Ltd(merged) 500373 CLARIANT
Clariant Chemicals (India) Ltd 506390 CLNINDIA
Clarisis Organics Ltd 524806
Claro India Ltd 524366
Cochin Minerals & Rutile Ltd 513353
Continental Petroleums Ltd 523232
Core Organics Ltd 524466
Crestchem Ltd 526269
Dai-ichi Karkaria Ltd 526821 DAICHIKARK
Deccan Petroleums Ltd 526375
Deepak Fertilizers & Petrochemicals Corp Ltd 500645 DEEPAKFERT
Deepak Nitrite Ltd 506401 DEEPAKNTR
Dharamsi Morarji Chemicals Co Ltd 506405 DHARAMORAR
DIC India Ltd 500089 DICIND
Diviya Chemicals Ltd 506810
Doctors Biotech India Ltd 512079
Dujodwala Paper Chemicals Ltd 524276
Elantas Beck India Ltd 500123 DRBECK
Ellenbarrie Industrial Gases Ltd 590087
Emmessar Biotech & Nutrition Ltd 524768
EPIC Enzymes Pharma & Industrial Chemicals Ltd 524374
Excel Industries Ltd 500650 EXCELINDUS
Fairchem Speciality Ltd 530117 FAIRCHEM
Ficom Organics Ltd(merged) 506443 FICOMORGAN
Fine Organic Industries Ltd 541557 FINEORG
Fineotex Chemical Ltd 533333 FCL
Fischer Chemic Ltd 524743
Foseco India Ltd 500150 FOSECOIND
Futuristic Offshore Services and Chemical Ltd 500154 GANESHANHY
Gagan Gases Ltd 524624
Galaxy Oleo-Chem (India) Ltd 40207
Ganesh Benzoplast Ltd 500153 GANESHBENZ
GBL Industries Ltd 539009
GFL Ltd 500173 GFLLIMITED
GHCL Ltd 500171 GHCL
Glory Chemicals Ltd 531532
Goa Carbon Ltd 509567 GOACARBON
GOCL Corporation Ltd 506480 GOCLCORP
Godrej Industries Ltd 500164 GODREJIND
Goiex Michio Sudo Ltd 507978
GOM Industries Ltd 523802
Goodearth Industries Ltd 526929
Goodearth Organic (India) Ltd [Wound-up] 524300
Govind Poy Oxygen Ltd 509586
GP Petroleums Ltd 532543 GULFPETRO
Grauer & Weil (India) Ltd 505710
Gresoil (India) Ltd 530483
Gujarat Carbon & Industries Ltd 506457
Gujarat Fluorochemicals Ltd 542812 FLUOROCHEM
Gujarat Indo-Lube Ltd 523552
Gujarat Oiland Industries Ltd (Wound Up) 507866
Gujarat Organics Ltd 501368
Gujarat Speciality Lubes Ltd 523880
Gujchem Distillers India Ltd 506640
Gulf Oil India Ltd - Merged 511026 GULFOIL
Gulf Oil Lubricants India Ltd 538567 GULFOILLUB
Gulshan Polyols Ltd 532457 GULPOLY
Gulshan Sugars & Chemicals Ltd(merged) 524184
Haryana Leather Chemicals Ltd 524080
Hemo Organic Ltd 524590
Hico Products Ltd 506461
Hilltone Industrial Gases Ltd 40441
Himadri Speciality Chemical Ltd 500184 HSCL
Hindcon Chemicals Ltd 535053 HINDCON
Hindustan Industrial Chemicals Ltd 524679 HINDINDCHM
Hindustan Organic Chemicals Ltd 500449 HOCL
Hindustan Oxygen Gas Ltd 509660
Hubergroup India Pvt Ltd 523886 MICRO
I G Petrochemicals Ltd 500199 IGPL
IBP Co. Ltd(merged) 500198 IBP
Iccon Oil & Specialities Ltd 523766
India Carbon Ltd 40012
India Gelatine & Chemicals Ltd 531253
India Glycols Ltd 500201 INDIAGLYCO
Indian Electro Chemicals Ltd 506490
Indo Amines Ltd 524648
Indo Borax & Chemicals Ltd 524342
Indo Gulf Industries Ltd 506945
Indo Vanillon Chemicals Ltd 531267
Indu Nissan Oxo Chemicals Industries Ltd 500208 INDUNISSAN
Inox Air Products Pvt Ltd 526534 INDOXYGEN
Insilco Ltd 500211 INSILCO
Iota Chemiculture Ltd 524630
IVP Ltd 507580 IVP
J F Laboratories Ltd 523804 JFLABS
J.R. Organics Ltd 506650
Jay Agrochem Ltd (Wound Up) 513504
Jayant Agro Organics Ltd 524330 JAYAGROGN
Jocil Ltd 500561 JOCIL
Jyoti Resins and Adhesives Ltd 514448
K P Gelatines & Chemicals India Ltd (Wound-up) 524741
Kamar Chemicals & Industries Ltd 531001
Kanchi Karpooram Ltd 538896
Kanva Hydro Chem Ltd 524685
Karnataka Chemical Industries Corp Ltd 530105
Karnav Leather Chemicals Ltd 524432
Kavit Industries Ltd 524444
Keltech Energies Ltd 506528
Kesar Petroproducts Ltd 524174
Kilburn Chemicals Ltd 524699
Kings India Chemicals Corporation Ltd 524214
Kothari Polymers Ltd 40360
Krishna Plastochem Ltd (Wound Up) 524254
Laffans Petrochemicals Ltd 524522
Lime Chemicals Ltd 507759
Linde India Ltd 523457 LINDEINDIA
Link Pharma Chem Ltd 524748
Lords Chemicals Ltd 530039
M.P. Carbide & Chemicals Ltd 506925
Madras Petrochem Ltd 500261
Maha Chemicals Ltd (Wound-up) 524556
Maharashtra Explosives Ltd (Wound-up) 506871
Maharashtra Polybutenes Ltd 524232
Mangalam Organics Ltd 514418
Mark Omega Organic Industries Ltd 524681
Maruti Industrial Carbohydrates Ltd 524814
Maruti Organics Ltd 524402 MARUTIORNG
Master Chemicals Ltd 506867
Mehta Rubber Chemcials Ltd 526536
Mehta Sulfites (India) Ltd 530029
mk Aromatics Ltd 531011
Modipon Ltd 503776 MODIPON
Motorol (I) Ltd 508965 MOTOROL
Motorol Enterprises Ltd 523049 RINKIPETRO
Motorol Speciality Oils Ltd 506954
MTZ Industries Ltd 500275 METAZINC
Murablack India Ltd 523578 MURABLACK
Mysore Petro Chemicals Ltd 506734 MYSORPETRO
Nacro Chemicals Ltd 524350
Nariman Point Chemical Industries Ltd 524224
National Oxygen Ltd 507813 NOL
National Peroxide Ltd 500298 NATPEROXID
Navin Fluorine International Limited 532504 NAVINFLUOR
Neogen Chemicals Ltd 542665 NEOGEN
Newton Engineering & Chemicals Ltd 524474
Nikhil Adhesives Ltd 526159
Niraj Petrochemicals Ltd 500454 NIRAJPETRO
Nitta Gelatin India Ltd 506532 KERALACHEM
NLC Nalco India Ltd 524101 NALCOCHEM
Noble Explochem Ltd 506991
NOCIL Ltd 500730 NOCIL
Nova Chemie (India) Ltd 40188
Ojas Technochem Products Ltd(wound-up) 526427
Omkar Pharmachem Ltd 532167
Omkar Speciality Chemicals Ltd 533317 OMKARCHEM
Organic Coatings Ltd 531157
Orient Organics Ltd 524766
Oriental Aromatics Ltd 500078 OAL
Oriental Carbon & Chemicals Ltd 506579 OCCL
Orissaa Organics Ltd 524392
Oswali Chemicals Ltd 506916
Padmanabh Industries Ltd 526905
Paintex Chemicals (Bombay) Ltd 524178
Partap Industries Ltd 531926
Paschim Petrochem Ltd 531005
Pentasia Chemicals Ltd (Merged) 507739
Pentokey Organy (India) Ltd 524210
Phillips Carbon Black Ltd 506590 PHILIPCARB
Pidilite Industries Ltd 500331 PIDILITIND
Pinky Chemicals Ltd 524671
Plastiblends India Ltd 523648 PLASTIBLEN
POCL Enterprises Ltd 539195
Poddar Pigments Ltd 524570 PODDARMENT
Polyolefins Industries Ltd (Merged) 506610
Pondy Oxides & Chemicals Ltd 532626 PONDYOXIDE
Premier Explosives Ltd 526247 PREMEXPLN
Prolife Industries Ltd 538392 PROLIFE
Protchem Industries (India) Ltd 524117
Punjab Chemicals & Crop Protection Ltd 506618 PUNJABCHEM
Rain Calcining Ltd(merged) 532153 RAINCALCIN
Rathi India Ltd 506959
Refex Industries Ltd 532884 REFEX
Refnol Resins & Chemicals Ltd 530815
Rencal Chemicals (India) Ltd 524510
Resonance Specialities Ltd 524218
Revati Organics Ltd 524504
Rhodia Specialty Chemicals India Ltd 506230 ALBRMORARJ
Ritesh International Ltd 519097
Rock Hard Petro Chemical Industries Ltd 524194
Rukmani Metals & Gaseous Ltd 40695
S H Kelkar & Company Ltd 539450 SHK
S K R Chemicals Ltd 530371
Salvigor Laboratories Ltd (Merged) 524268
Sanderson Industries Ltd 507728 SANDERIND
Sanginita Chemicals Ltd 538408 SANGINITA
Sarang Chemicals Ltd 532031
Searsole Chemicals Ltd (Wound-up) 506644
Seya Industries Ltd 524324 SEYAIND
Shaba Chemicals Ltd 524546
Shaper Chemicals Ltd (Wound-up) 524566
Shayona Petrochem Ltd 531538
Shentracon Chemicals Ltd 530757
Shree Benzophen Industries Ltd 531389
Shree Neelachal Laboratories Ltd 531487
Shri Ambuja Petro Chemicals Ltd 506742
Shri Aster Silicates Ltd 533219 SHRIASTER
Shri Nicosect Ltd 526437
SI Group - India Ltd 506460 SIGROUPIND
SMZS Chemicals Ltd(wound-up) 524160 SMZSCHEM
Solar Industries India Ltd 532725 SOLARINDS
Sonal Sil Chem Ltd 524673
Southern Gas Ltd 509910
Speciality Petrolubes Ltd 523525
Sree Rayalaseema Hi-Strength Hypo Ltd 532842 SRHHYPOLTD
Sree Rayalaseema Petrochemicals Ltd (Merged) 524618
Sreechem Resins Ltd 514248
SRHHL Industries Ltd (Merged) 524410 SRHHLINDST
Sterling Biotech Ltd 512299 STERLINBIO
Sudev Chemicals Ltd 40666
Sumitomo Chemical India Ltd 542920 SUMICHEM
Sun Star Chemicals Ltd 524536 SUNSTRCHEM
Sunshield Chemicals Ltd 530845
Sunstar Lubricants Ltd 524452 SUNSTARLUB
Superior Air Products Ltd (Merged) 526469
Swarnajyothi Agrotech & Power Ltd 590090
Tamil Nadu Industrial Explosives Ltd 524028
Tanfac Industries Ltd 506854 TANFACIND
Tata Chemicals Ltd 500770 TATACHEM
TCM Ltd 524156
TECIL Chemical & Hydro Power Ltd 506680 TECILCHEM
Tetrahedron Ltd 40308
Thirani Chemicals Ltd (Merged) 524125
Thirumalai Chemicals Ltd 500412 TIRUMALCHM
Tide Water Oil Co (I) Ltd 590005 TIDEWATER
Tirupati Inks Ltd 533258
Transpek Industry Ltd 506687 TRANSPEK
Tria Fine Chem Ltd 524721
Tribology India Ltd 40171
Trigon Zinco Ltd 530287
Tulasee Bio-Ethanol Ltd 524514
Tyche Industries Ltd 532384
U P Lime Chem Ltd 524677
Unique Oils India Ltd 523250
Urvi Chemicals & Allied Industries Ltd 501371
Vadilal Chemicals Ltd 40485
Vadivarhe Speciality Chemicals Ltd 538429 VSCL
Valiant Organics Ltd 540145
Vasundhara Rasayans Ltd 538634
VBC Industries Ltd 524310
Vibros Organics Ltd 530487
Vijayshree Chemicals (India) Ltd 524312
Vinati Organics Ltd 524200 VINATIORGA
Vishnu Chemicals Ltd 516072 VISHNU
Vision Organics Ltd 532383 VISIONLTD
Yasho Industries Ltd 541167

Share Holding

Category No. of shares Percentage
Total Foreign 32480 0.54
Total Institutions 472 0.01
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 393801 6.51
Total Promoters 4537189 75.00
Total Public & others 1085645 17.94
Total 6049587 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

About Narmada Gelatines Ltd

Narmada Gelatines Ltd., formerly known as Shaw Wallace Gelatines was incorporated on 13 Jan.'61 as Leiner-Knit Gelatin Company. In 1978, the original promoters P Leiner & Sons fully divested in favour of Shah Wallace & Company and the name was changed to the Shaw Wallance Gelatines. The company manufactures gelatine, ossein, dicalcium phosphate and bone meal. Gelatine is basically a protein derivative of collagen, with a wide variety of end users. It is mostly used in the pharmaceutical, food and photographic industries. The company came out with an issue of PCDs in Dec.'94 to part-finance the expansion of existing capacity of production of gelatine from 1500 tpa to 2000 tpa. In 1994-95, the company made a breakthrough in exports of gelatine of pharmaceutical grade to developed countries, and edible grade to Japan and the Netherlands. Crushed bones of different sizes are washed, de-greased and processed for de-mineralisation. In de-mineralisation, the bones are treated with chilled dilute mineral acid in wooden vats to remove calcium phosphate from the bone pieces. This results in soft bones which are called ossein. After acid-free wash, this goes through alkaline treatment to remove unwanted proteins, fats and sugars, improving the purity of the collagen. The resultant product after refining is gelatine. Company consolidated its position in exporting pharmaceutical and edible grades of Gelatine to developed countries. Company has projected aprox. 134% Export, taking efforts to enter into the Japanese market to export of Ossein. Company has accredited with ISO-9002 Certificate by BVQI. The company is planning to improve the gelatine quality parameter in order to export more value product.

Narmada Gelatines Ltd Chairman Speech

Narmada Gelatines Ltd Company History

Narmada Gelatines Ltd., formerly known as Shaw Wallace Gelatines was incorporated on 13 Jan.'61 as Leiner-Knit Gelatin Company. In 1978, the original promoters P Leiner & Sons fully divested in favour of Shah Wallace & Company and the name was changed to the Shaw Wallance Gelatines. The company manufactures gelatine, ossein, dicalcium phosphate and bone meal. Gelatine is basically a protein derivative of collagen, with a wide variety of end users. It is mostly used in the pharmaceutical, food and photographic industries. The company came out with an issue of PCDs in Dec.'94 to part-finance the expansion of existing capacity of production of gelatine from 1500 tpa to 2000 tpa. In 1994-95, the company made a breakthrough in exports of gelatine of pharmaceutical grade to developed countries, and edible grade to Japan and the Netherlands. Crushed bones of different sizes are washed, de-greased and processed for de-mineralisation. In de-mineralisation, the bones are treated with chilled dilute mineral acid in wooden vats to remove calcium phosphate from the bone pieces. This results in soft bones which are called ossein. After acid-free wash, this goes through alkaline treatment to remove unwanted proteins, fats and sugars, improving the purity of the collagen. The resultant product after refining is gelatine. Company consolidated its position in exporting pharmaceutical and edible grades of Gelatine to developed countries. Company has projected aprox. 134% Export, taking efforts to enter into the Japanese market to export of Ossein. Company has accredited with ISO-9002 Certificate by BVQI. The company is planning to improve the gelatine quality parameter in order to export more value product.

Narmada Gelatines Ltd Directors Reports

The Directors present the 57th Annual Report of Narmada Gelatines Limited (the Company) along with the audited financial statements for the financial year ended 31st March, 2018.

Financial Highlights (Rs lakh)
Yearended 31st March, Year ended 31st March,
2018 2017
Revenue from Operations 11761.23 11275.51
Other Income 439.79 584.18
Total Income 12201.02 11859.68
Total expenses 11351.10 11027.38
Profit before tax 849.92 832.30
Tax Expense 46.23 221.72
Profit after taxation 803.69 610.59
Other Comprehensive Income: Re-measurements of net defined benefit plans 15.22 14.19
Net Profit for the year 818.92 624.78

Economy Overview

India's economic growth in 2017-18 experienced a slowdown to 6.6% from 7.1% in the previous year. The first quarter of the financial year 2017-18 saw the impact of demonetisation settling down, while in the next quarter, the introduction of the landmark Goods and Services Tax (GST) brought in some uncertainties as businesses adjusted to the new regime. This did not take long, and from the third quarter onwards, signs of growth returning were evident.

Sectors such as public administration, defence and other services, trade, hotels, transport, communication and services related to broadcasting, electricity, gas and water supply and other utility services, financial, real estate and professional services registered a growth of over 7%.

Industrial growth also recovered with the Index of Industrial production (IIP) registering an impressive growth rate of 7.5% in January 2018 as compared to 2.4% in January 2017. The cumulative growth for the year stood at 3.7% in contrast to 5.1% growth registered during 2016-17.

Manufacturing sectors such as pharmaceuticals, electronics and transport equipment registered robust double-digit growth rates, while growth in other sectors such as electrical equipment, garments and textiles slackened.

Indian exports exhibited positive growth during the year 2017-18 and expanded by around 11% over the previous year.

Operating Performance

During the year under review, despite the economic slowdown in first half, your company recorded a turnover (net of excise) of Rs 117.61 crores as compared to Rs 112.75 crores in the previous year. Profit after tax at Rs 8.03 crores improved significantly as compared to Rs 6.10 crores in 2016-17 as a result of reduction in tax expense. Consequently, Earnings per share increased to Rs 13.54 as compared to Rs 10.33 in 2016-17.

Dividends

Based on the company's performance, the Directors are pleased to recommend a dividend of Rs 4.00 per Equity Share (previous year Rs4.00 per Equity Share) for the financial year ended 31st March, 2018. The total outflow on account of the

proposed dividend including dividend distribution tax will be Rs 291.72 lakh (previous year Rs291.24 lakh). The dividend on equity shares, if approved at the ensuing Annual General Meeting, will be paid to Members whose names appear in the Register of Members as on 19th September, 2018 and to Members whose names appear on that date as Beneficial Owners as furnished by National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL).

Transfer to Reserves

It is proposed to transfer an amount of Rs 81.89 lakh (being 10% of the net profits for the year) to the General Reserve.

Industry Structure and Developments

Global gelatin market is expected to grow at a rate of 2% to 3% per annum. Increasing use in nutraceuticals, recognition of preventive healthcare, growing demand for technical textile and utilization of functional food are the major factors driving the market growth. Pharmaceutical applications are expected to witness fastest growth on account of rapidly expanding usage of hydrocolloids in production of tablets and capsules. However, food security concerns and threat of vegan gelatin substitutes are some of the factors hindering the market growth.

Pig skin segment holds the maximum share of the gelatin market. Huge amount of collagen found in pig skin is one of the key factors driving this segment. Bovine hides and bones are unrefined materials that are used broadly in the market, and both these segments combined together account for less than 60% share of the overall gelatin market.

Growing regulatory issues, primarily in the food industry, are also challenges for domestic gelatin manufacturers.

Opportunities and Threats, Outlook, Risks and Concerns

India continues to be categorised as "Negligible Risk" under BSE categorisation. With increasing level of awareness on environmental hazards, the state authorities are upgrading pollution control norms regularly and the industry is now required to address the issue of environment with more commitment. Your company continues to take all necessary steps to comply with pollution control norms.

Difficulty in sourcing good quality raw material and rise in raw material prices continue to areas of concern. The import of poor quality gelatin into India is a matter of health concern and affects proper price realisation for the gelatin produced by the domestic manufacturers. The industry has been taking pro-active steps to make the Government authorities aware of such imports. Furthermore, availability of cheap raw materials has pushed down the gelatine prices globally. This has the impact on pricing in the domestic market. Large quantities of gelatin are being imported into India at prices lower than the domestic prices, which is a major concern for the industry. The availability of good quality crushed bones at a reasonable cost is critical for the competitiveness of the domestic ossein and gelatin industry. The government has allowed imports of crushed bones and the quality of the imported bones is far superior. This may help to reduce the raw material prices in India and also help to improve the quality of gelatin.

The growth of the market for food gelatin is driven by the end-use industries, such as confectionery, nutritional drinks and bakery. Although the market is growing, it is facing different challenges that include low acceptance from strict vegetarians and religious groups. While your company is taking all actions to improve product mix, yield and productivity along with cost reduction measures, the price realisation for gelatin and consequently the margins are constantly facing pressure. The prima facie indications from the Government to replace the gelatin capsules by Hydro-

xypropylmethyl cellulose (HPMC) is a major challenge being faced by the industry over the past year. For the time being, this has been set to rest as the recommendation of expert committee appointed by the Government is in favour of continuing with gelatin capsules for medicinal use.

Segment-wise or product-wise performance

The Company is engaged in only one segment namely manufacture and sale of gelatine and related products like ossein and di-calcium phosphate (DCP) and as such there are no reportable segments as per Ind AS-108 "Operating Segments"

Quality initiatives

The Company is committed to the highest levels of quality for its products and customer services. During the financial year 201718, the Company retained its ISO certification for Quality Management (ISO 9001:2008), EDQM Certification from European Directorate for the Quality of Medicines and Healthcare, DNV Management System Certification for Food Safety Management System Standard (ISO 22000:2005), KOSHER Certification, Halal Assurance System Certification from Majelis Ulama, Indonesia.

Internal financial controls and its adequacy

The Company has designed and implemented a process driven framework for Internal Financial Controls within the meaning of the explanation to Section 134(5)(e) of the Companies Act, 2013. Based on the framework of internal financial controls and compliance systems established and maintained by the Company, work performed by the Internal, Statutory and Secretarial Auditors, including audit of the internal financial controls over financial reporting by the Statutory Auditors, and the reviews performed by Management and the relevant Board Committees, including the Audit Committee, the Board is of the opinion that the Company's internal financial controls were adequate and effective during the financial year 2017-18 and commensurate with the nature and size of its business operations and operating effectively and no material weakness exists. The Company has a process in place to continuously monitor the same and identify gaps, if any, and implement new and/or improved controls wherever the effect of such gaps would have a material effect on the Company's operations.

The Company's internal control system comprises audit and compliance of observations made by the Internal Auditor. The Internal Auditor independently evaluates the adequacy of internal controls and concurrently audits the majority of the transactions in value terms. Independence of audit and compliance is ensured by direct reporting of Internal Auditor to the Audit Committee. Statutory and Internal Auditors undertake rigorous testing of the control environment of the Company.

Fixed Deposits

During the year under review, the Company has not accepted any deposits from public as defined under Chapter V of the Companies Act, 2013 and as such, no amount on account of principal or interest on deposits from public was outstanding as on the date of the balance sheet.

Particulars of Loans, Guarantees or Investments

Details of Loans, Guarantees and Investments covered under the provisions of Section 186 of the Companies Act, 2013 are given in the notes to the Financial Statements.

Corporate Social Responsibility (CSR)

The brief outline of the corporate social responsibility (CSR) policy of the Company and the initiatives undertaken by the Company on CSR activities during the year are set out in Annexure I of this report in the format prescribed in the

Companies (Corporate Social Responsibility Policy) Rules, 2014. For other details regarding the CSR Committee, please refer to the Corporate Governance Report, which is a part of this report. The policy is available on https://www.narmadagelatines.com .

Risk Management

The Board of Directors of the Company has formed a Risk Management Committee to frame, implement and monitor the risk management plan for the Company. The Risk Management Committee is entrusted with the responsibility to assist the Board in overseeing the risks associated with the business and risk mitigating measures to be taken by the Company. The details of the Risk Management Committee, its terms of reference, key business risks identified and mitigation plans are set out in the Corporate Governance Report.

Vigil Mechanism

As per the provisions of Section 177(9) of the Companies Act, 2013 ('Act'), the Company is required to establish an effective Vigil Mechanism for directors and employees to report genuine concerns. The Company has a Whistle-blower Policy in place to encourage and facilitate employees to report concerns about unethical behaviour, actual/suspected frauds and violation of Company's Code of Conduct or Ethics Policy. The policy provides for adequate safeguards against victimisation of persons who avail the same and provides for direct access to the chairperson of the Audit Committee. The Audit Committee of the Company oversees the implementation of the Whistle-Blower Policy. The Company has disclosed information about the establishment of the Whistle-Blower Policy on its website www.narmadagelatines.com and in the Corporate Governance Report

Subsidiaries, Joint Ventures and Associate Companies

The Company does not have any subsidiary, joint ventures or associate companies.

Directors and Key Managerial Personnel

In accordance with the provisions of Section 152 of the Companies Act, 2013, and Article 115 of the Articles of Association of the Company, Ms. Drushti R Desai retires by rotation at the ensuing Annual General Meeting of the Company and being eligible, has offered herself for re-appointment. The Board of Directors recommends her re-appointment.

Pursuant to the provisions of Section 149 of the Act, Mr. Gulab Gupta, Mr. Mohan C Pant and Mr. Deepak Chaudhari are Independent Directors of the Company. They have submitted a declaration that each of them meet the criteria of independence as provided in Section 149(6) of the Act and Regulation 16(1)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. There has been no change in the circumstances affecting their status as an Independent Director during the year.

During the year, Ms. Garvita Asati has been designated as Chief Financial Officer of the Company with effect from August 7, 2017.

Attention of Shareholders is invited to the relevant items of the Notice of the Annual General Meeting and the Notes thereto. Brief resume of the Director proposed to be reappointed, nature of her expertise in specific functional areas and names of companies in which she holds directorship and membership/ chairmanship of committees of the Board, as stipulated under Regulation 36 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are given in the section on Corporate Governance in this Annual Report.

Board Evaluation

The Nomination & Remuneration Committee and the Board have laid down the manner in which formal annual evaluation of the performance of the Board, Committees, Chairman and individual

directors has to be made. The Board of Directors has carried out an annual evaluation of its own performance, board committees, and individual directors pursuant to the provisions of the Act, SEBI Listing Regulations and the Guidance Note on Board Evaluation issued by the Securities and Exchange Board of India.

The performance of the board was evaluated by the board after seeking inputs from all the directors on the basis of criteria such as the board composition and structure, effectiveness of board processes, information and functioning, etc. The performance of the committees was evaluated by the board after seeking inputs from the committee members on the basis of criteria such as the composition of committees, effectiveness of committee meetings, etc.

In a separate meeting of independent directors, performance of non-independent directors and the board as a whole was evaluated, taking into account the views of executive directors and non-executive directors.

The Board and the Nomination and Remuneration Committee reviewed the performance of individual directors on the basis of criteria such as the contribution of the individual director to the board and committee meetings like preparedness on the issues to be discussed, meaningful and constructive contribution and inputs in meetings, etc. In the board meeting that followed the meeting of the independent directors and meeting of Nomination and Remuneration Committee, the performance of the board, its committees, and individual directors was also discussed.

Performance evaluation of independent directors was done by the entire board, excluding the independent director being evaluated. The manner in which the evaluation has been carried out is covered in the Corporate Governance Report.

Policy on Directors' Appointment and Remuneration

The policy of the Company is to have an appropriate number of executive and independent directors on the board.

The policy of the Company on directors' appointment and remuneration, etc. as required under Section 178 of the Companies Act, 2013, is available on the Company's website (www.narmadagelatines.com ) and in the Corporate Governance Report. There has been no change in the policy since the last financial year. The remuneration paid to the directors is as per the terms laid down in the Nomination & Remuneration Policy of the Company.

Meetings

During the financial year under review, four Board Meetings and four Audit Committee Meetings were convened and held, the details of which are given in the Corporate Governance Report. The intervening gap between two Meetings was within the period prescribed under the Companies Act, 2013.

Directors' Responsibility Statement

Pursuant to Section 134(5) of the Act, the Board of Directors, to the best of its knowledge and ability, confirm that:

a. in the preparation of the annual financial statements for the year ended March 31, 2018, the applicable accounting standards have been followed along with proper explanation relating to material departures, if any;

b. appropriate accounting policies have been selected and applied consistently and judgements and estimates made are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company as at March 31,2018 and of the profit of the Company for the year ended on that

date;

c. proper and sufficient care has been taken for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 2013 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

d. the annual financial statements have been prepared on a going concern basis;

e. proper internal financial controls have been followed and that such financial controls are adequate and are operating effectively; and

f. proper systems to ensure compliance with the provisions of all applicable laws are in place and were adequate and operating effectively.

Related Party Transactions

All related party transactions that were entered into during the financial year were on an arm's length basis and were in the ordinary course of business. There are no materially significant related party transactions made by the Company with Promoters, Directors, Key Managerial Personnel or other designated persons which may have a potential conflict with the interest of the Company at large.

Particulars of contracts or arrangements with related parties referred to in Section 188(1) of the Companies Act, 2013 in Form AOC-2 are set out in the Note 35 of Notes to Financial Statements forming part of the Annual Report. None of the Directors have any pecuniary relationships or transactions with the Company or vice versa

Statutory Auditors and Audit Report

Pursuant to the provisions of Section 139 of the Act read with Companies (Audit and Auditors) Rules, 2014, as amended from time to time, M/s Lodha and Company, Mumbai, Chartered Accountants (Firm Registration No.301051E), were appointed as statutory auditors from the conclusion of 56th Annual General Meeting of the Company, till the conclusion of 61st Annual General Meeting to be held in 2022. However, as per the Companies Amendment Act, 2017 enforced on 7th May, 2018 by the Ministry of Corporate Affairs, the appointment of Statutory Auditors is now not required to be ratified at every Annual General Meeting.

The Statutory Auditors, M/s Lodha and Company, Mumbai, Chartered Accountants, have submitted their Report on the Financial Statements of the Company for the Financial Year 201718, which forms part of the Annual Report 2017-18. The Notes on Financial Statements referred to in the Auditors' Report for the year 2017-18 are self-explanatory. There are no observations, qualifications, reservations or adverse remarks of the Auditors in the Auditor's Report that call for any explanation.

Secretarial Audit

Pursuant to the provisions of Section 204 of the Companies Act, 2013 and The Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, Dr. Asim Kumar Chattopadhyay, Company Secretary in Practice, was appointed to undertake the Secretarial Audit of the Company. The Secretarial Audit Report is annexed to this Report as Annexure - II. The Secretarial Audit Report does not contain any qualifications, reservations or adverse remarks.

Transfer of Unpaid and Unclaimed amounts to IEPF

Pursuant to the provisions of Section 124 of the Companies Act, 2013, the declared dividends and interest on debentures which remained unpaid or unclaimed for a period of 7 years have been transferred by the Company to the Investor Education and Protection Fund (IEPF) established by the Central Government

pursuant to Section 125 of the said Act. During the financial year 2017-18, the Company has transferred to the Investor Education and Protection Fund, unclaimed dividends as detailed in the Corporate Governance Report.

The Company has uploaded the details of unpaid and unclaimed amounts lying with the Company as on 20th September, 2017 (date of last Annual General Meeting) on the website of the Ministry of Corporate Affairs.

Significant and Material Order passed by the Regulators

There are no significant and material orders passed by the Regulators or Courts or Tribunals impacting the going concern status and the Company's operations in future.

Corporate Governance Report

The Report on Corporate Governance as stipulated under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 forms part of the Annual Report. The Wholetime Director's declaration regarding compliance with the Company's Code of Business Conduct and Ethics for Directors and Management Personnel forms part of the Corporate Governance Report. As required by the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the certificate on Corporate Governance for the year ended 31st March, 2018 issued by Dr. Asim Kumar Chattopadhyay, Company Secretary in Practice, is annexed to this Report.

Energy Conservation, Technology Absorption and Foreign Exchange Earnings and Outgo

The particulars relating to energy conservation, technology absorption, foreign exchange earnings and outgo, as required to be disclosed under Section 134(3)(m) of the Companies Act,

2013 read with Rule 8(3) of The Companies (Accounts) Rules,

2014 is annexed to this Report as Annexure - III.

Extract of Annual Return

In accordance with the Section 134(3)(a) of the Companies Act, 2013 an extract of the Annual Return in Form MGT-9 is annexed to this Report as Annexure - IV.

Particulars of Employees

None of the employees of the Company is in receipt of remuneration exceeding the limits prescribed under Section 197(12) of the Companies Act, 2013 read with Rule 5(2) and 5(3) of The Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014.

Disclosures pertaining to remuneration and other details in respect of directors and employees of the Company as required under Section 197(12) of the Companies Act, 2013 read with Rule 5(1) of The Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is annexed to this Report as Annexure - V.

Disclosure under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013

All the employees in the Company are considered equal. There is no discrimination between individuals at any point on the basis of race, colour, gender, religion, origin, sexual orientation or age. Every individual is expected to treat his/her colleagues with respect and dignity. The Company has in place a policy for prevention of sexual harassment at workplace. This Anti- Sexual Harassment Policy of the Company is in line with the requirements of The Sexual Harassment of Women at the Workplace (Prevention, Prohibition & Redressal) Act, 2013. All employees (permanent, contractual, temporary and trainees) are covered under this policy. An Internal Complaints Committee is in place to redress complaints received regarding sexual harassment. No complaint was received by the Company during the financial year ended 31st March, 2018.

Material changes and commitments affecting the financial position of the Company

There have been no material changes and commitments affecting the financial position of the Company which have occurred between the end of the financial year of the Company to which the financial statements relate and the date of this report.

Human Resources / Industrial Relations

The Company's human resources agenda continues to remain focused on the development of its employees, building capabilities in the organization and progressive employee relations policies.

Industrial relations remained cordial throughout the year. Your Directors place on record their sincere appreciation of the significant contributions made and the continued support extended by all employees at all levels to the Company's operations during the year.

Acknowledgement

Your Directors take this opportunity to thank the Central and the State Governments, statutory authorities, bankers, vendors and business associates and all the stakeholders for their continued interest and valued support.

For and on behalf of the Board

Ravindra K. Raje Ashok K. Kapur

Director Whole-time Director

Place: Jabalpur Date: 29th May, 2018

   

Narmada Gelatines Ltd Company Background

Incorporation Year1961
Registered OfficeCARAVS Room No.28,15 Civil Lines
Jabalpur,Madhya Pradesh-482001
Telephone91-0761-2678627,Managing Director
Fax91-0761-2678864
Company SecretaryMahesh Verma
AuditorLodha & Co
Face Value10
Market Lot1
ListingBSE,
RegistrarCB Management Services Ltd
P-22,Bondel Road, ,Kolkata-700019

Narmada Gelatines Ltd Company Management

Director NameDirector DesignationYear
Sanjeev Jain Director 2017
Gulab Gupta Independent Director 2017
Deepak Chaudhuri Independent Director 2017
Mohan Chandra Pant Independent Director 2017
Ravindra K Raje Director 2017
Ashok K Kapur Whole-time Director 2017
Mahesh Verma Company Secretary 2017
Drushti R Desai Director 2017

Narmada Gelatines Ltd Listing Information

Narmada Gelatines Ltd Finished Product

Product NameUnit Installed
Capacity
Production
Quantity
Sales
Quantity
Sales
Value
Gelatin MT 00091.7532
Dicalcium Phosphate MT 00029.7713
Ossein MT 0003.7296
Bone Product-Others MT 0000.4935
Bone Meal MT 0000
Excise Duty NA 0000
Others NA 0000
Trade Discount NA 0000

Contact us